MetaCap

Global Moderately Aggressive Allocation ETFs

4 global moderately aggressive allocation ETFs ranked by assets under management. Updated October 9, 2026.

Total assets
$4.0B

MetaCap lists 4 US-listed ETFs in the Global Moderately Aggressive Allocation category, holding a combined $4.0B in assets. The largest by assets are AOA ($3.3B), ELM ($590.9M) and PPI ($155.5M). Expense ratios range from 0.15% to 1.09% (median 0.40%); AOA is the lowest-cost fund shown at 0.15% a year. On the latest trading day, 3 of 4 funds were higher, with an average move of +0.35%.

Summary generated from market data by MetaCap's automated system. Methodology

Largest global moderately aggressive allocation ETFs by assets

Global Moderately Aggressive Allocation ETFs by assets under management
#SymbolFund NamePrice% ChangeAUM
1AOAiShares Core 80/20 Aggressive Allocation ETF97.90+0.43%$3.29B
2ELMElm Market Navigator ETF29.41+0.17%$590.94M
3PPIAstoria Real Assets ETF20.43+0.81%$155.46M
4KNOWFundamentals First ETF12.700.00%$8.50M

Frequently asked questions

How many global moderately aggressive allocation ETFs are there?
MetaCap tracks 4 US-listed global moderately aggressive allocation ETFs with about $4.0B in combined assets.
What is the largest global moderately aggressive allocation ETF?
iShares Core 80/20 Aggressive Allocation ETF (AOA) is the largest, with about $3.3B in assets under management.
Which Global Moderately Aggressive Allocation ETF has the lowest expense ratio?
Among the funds shown, iShares Core 80/20 Aggressive Allocation ETF (AOA) has the lowest expense ratio at 0.15% per year, or $15 a year on a $10,000 investment.
What does AUM mean for an ETF?
Assets under management (AUM) is the total market value of everything the fund holds. Larger ETFs tend to have tighter bid-ask spreads and more trading volume, but size alone does not make a fund a better investment.

Explore more ETFs

Prices as of Oct 9, 1:32 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer